Mood Disorder Questionnaire (MDQ)
iatroX editorial team · Updated · Record checked · editorial policy
The Mood Disorder Questionnaire is a brief screening tool for bipolar spectrum disorders. It assesses 13 symptoms of mania/hypomania, whether they occurred together, and their impact. A positive screen requires ≥7 symptoms + clustering + moderate-serious impairment.
questionnaire
evidence
derivation
Developed by Hirschfeld et al. (Am J Psychiatry 2000) as a brief self-report bipolar disorder screening tool based on DSM-IV manic episode criteria.
validation
Sensitivity 73%, specificity 90% for any bipolar disorder in the original psychiatric outpatient validation. Lower sensitivity in community and primary care populations (~28%) — suggesting it works better in enriched clinical populations.
guideline endorsements
NICE CG185 advises against using questionnaires in primary care to identify bipolar disorder in adults. Ask about previous overactivity or disinhibited behaviour and arrange specialist assessment when indicated. MDQ use in other settings requires clinical follow-up.
references
- Hirschfeld RMA, Williams JBW, Spitzer RL, et al. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000;157(11):1873-1875.PMID: 11058490
- NICE Clinical Guideline CG185. Bipolar disorder: assessment and management. 2014 (updated 2023).link ↗
- Supporting guidance — nice.org.uk (checked 14 November 2026).link ↗